103 filings
25-NSE
The Nasdaq Stock Market LLC
2 May 23
Exchange delisting
1:36pm
8-K
PEARQ
Pear Therapeutics, Inc.
10 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:36pm
8-K
PEARQ
Pear Therapeutics, Inc.
7 Apr 23
Termination of a Material Definitive Agreement
11:32am
10-K
2022 FY
PEARQ
Pear Therapeutics, Inc.
Annual report
31 Mar 23
4:01pm
8-K
PEARQ
Pear Therapeutics, Inc.
17 Mar 23
Pear Therapeutics Announces Process Exploring Strategic Alternatives
9:17am
8-K
z18hbcdjvwsyj
24 Feb 23
Departure of Directors or Certain Officers
4:05pm
S-8
tziy83
9 Feb 23
Registration of securities for employees
4:42pm
EFFECT
svqul
12 Jan 23
Notice of effectiveness
12:15am
424B5
4y2kj
10 Jan 23
Prospectus supplement for primary offering
4:20pm
UPLOAD
o2sbjhjn3etuuw3 ov
6 Jan 23
Letter from SEC
12:00am
CORRESP
zogmvb fdv1ay9
6 Jan 23
Correspondence with SEC
12:00am
424B3
mnev03wxp3ns
4 Jan 23
Prospectus supplement
4:19pm
EFFECT
urpeu4degq12y574y7
4 Jan 23
Notice of effectiveness
12:15am
POS AM
ftwzy
3 Jan 23
Prospectus update (post-effective amendment)
7:37am
424B3
45orfbrd xpxovs7
3 Jan 23
Prospectus supplement
6:39am
8-K
qsb ywta7ml1tb8uqx
3 Jan 23
Entry into a Material Definitive Agreement
6:33am
S-3
0qsy4n9njs027x
3 Jan 23
Shelf registration
6:04am
424B3
52q1 fdmemjz
14 Nov 22
Prospectus supplement
5:21pm
8-K
765f9n
14 Nov 22
Pear Therapeutics Reports Third Quarter 2022 Results
4:05pm